Cubist Systematic Strategies, LLC Accelerate Diagnostics, Inc Transaction History

Cubist Systematic Strategies, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.01 - $17.0 $18,955 - $319,056	18,768 New	18,768 $29,000
Q1 2022 May 16, 2022	SELL	$1.4 - $5.15 $17,010 - $62,572	-12,150 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$4.27 - $6.97 $24,603 - $40,161	-5,762 Reduced 32.17%	12,150 $63,000
Q3 2021 Nov 15, 2021	BUY	$5.31 - $8.25 $95,112 - $147,774	17,912 New	17,912 $104,000
Q1 2021 May 17, 2021	SELL	$7.99 - $15.0 $510,449 - $958,290	-63,886 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$7.04 - $11.7 $75,820 - $126,008	10,770 Added 20.28%	63,886 $484,000
Q3 2020 Nov 16, 2020	BUY	$9.98 - $18.04 $302,144 - $546,161	30,275 Added 132.55%	53,116 $566,000
Q2 2020 Aug 14, 2020	BUY	$7.49 - $15.16 $18,268 - $36,975	2,439 Added 11.95%	22,841 $346,000
Q1 2020 May 15, 2020	BUY	$4.62 - $18.74 $94,257 - $382,333	20,402 New	20,402 $170,000
Q2 2019 Aug 14, 2019	SELL	$17.79 - $22.88 $12,239 - $15,741	-688 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$11.76 - $22.15 $8,090 - $15,239	688 New	688 $14,000

549K

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $191M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.